Working out of offices in Stockholm and Copenhagen, Eir has raised a 122 million euro ($138 million) life science venture fund, positioning it to bet on biotechs in the Nordics and further afield. Eir secured the funding to help realize the potential of Nordic research.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,